TAG:
competitive bid
Two Blood Brothers Use “Free Testing” Strategy
By Robert Michel | From the Volume IX No. 12 – August 26, 2002 Issue
CEO SUMMARY: It’s a business strategy that Quest Diagnostics Incorporated and Laboratory Corporation of America use in selected areas where they have lost exclusive managed care contracts to regional lab competitors. In order to retain access to a physician’s fee-for-service testing b…
Big Fight is Brewing Over Lab Test Reimbursement
By R. Lewis Dark | From the Volume IX No. 8 – June 3, 2002 Issue
BY NOW, MOST LAB EXECUTIVES AND PATHOLOGISTS AGREE that Medicare Part B fees and reimbursement guidelines for lab testing have just about become de facto national standards. That’s because private payers increasingly use Medicare as the basis for building their own pricing and reimbursement guideli…
CPI Lab Fee Adjustment Threatened by New Bill
By Robert Michel | From the Volume IX No. 8 – June 3, 2002 Issue
CEO SUMMARY: Once again, the laboratory testing industry has been singled out as a healthcare “whipping boy” by Congressional aides. In working to develop the next federal budget, legislators again propose to deny annual CPI price updates for laboratory tests. This won’t be anything…
NH Rural Hospital Labs Connecting Via Internet
By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue
CEO SUMMARY: Expect the Internet to be a tool for leveling the competitive playing field. Ten rural hospital labs in New Hampshire are now connecting their labs and their outreach physician office clients with a Web-based lab test ordering and results reporting system. The goal is to incr…
Proposed Federal Budget Threatens Laboratories
By R. Lewis Dark | From the Volume VII No. 3 – February 14, 2000 Issue
BY NOW MOST OF YOU KNOW THAT PRESIDENT CLINTON’S FY01 BUDGET is not kind to the clinical laboratory industry. It seeks to restore the 20% copayment for lab services, cuts 30% out of the reimbursement for four tests, and institutes the Medicare competitive bidding concept for lab services. Over the…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized